Figure (Ble05 0000 01)
Chemical structure diagram of the active ingredient Bleomycin Sulfate, showing its molecular components and bonds.*
Bleomycin Powder, For Solution
Product Images NDC 71288-107
5 FDA label images from Meitheal Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 71288-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Ble05 0000 02)
Label for Bleomycin for Injection, USP, 15 units per vial, powder for solution. The label warns that it is a cytotoxic agent and must be diluted. It is for intravenous, intramuscular, subcutaneous, or intrapleural use and is a single-dose vial distributed by Meitheal Pharmaceuticals Inc. Storage instructions indicate keeping the dry powder under refrigeration between 2 to 8°C (36 to 46°F).*
Figure (Ble05 0000 03)
Bleomycin for Injection, USP 30 units per vial powder for solution, labeled for intravenous, intramuscular, subcutaneous, or intrapleural use. Single-dose vial. The label indicates it is a cytotoxic agent, lyophilized, sterile, nonpyrogenic, and preservative-free. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL. The label includes handling instructions and storage conditions between 2° and 8°C (36° and 46°F).*
Ble05 0000 04
Packaging label for Bleomycin for Injection USP, 15 units per vial, a powder for solution. Label specifies must be diluted for intravenous, intramuscular, subcutaneous, or intrapleural use. Caution: Cytotoxic Agent is highlighted in red. The label includes storage instructions and manufacturer Meitheal Pharmaceuticals Inc., Chicago IL. Single-dose vial, NDC 71288-106-10.*
Ble05 0000 05
The image shows the flat layout of the packaging label for Bleomycin for Injection, USP, 30 units per vial powder for solution. The label indicates this is a single-dose vial requiring dilution for intravenous, intramuscular, subcutaneous, or intrapleural use. It includes cautions stating it is a cytotoxic agent and provides storage instructions. The labeler is Meitheal Pharmaceuticals Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
